Related Experiment Videos
Synthesis of chromophoric dehydro analog of leucine enkephalin
International Journal of Peptide and Protein Research
|October 1, 1981
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Stathmo-apoptosis: arresting apoptosis by fluorochrome-labeled inhibitor of caspases.
International journal of oncology·2001
Comparative studies of glutathione reductase and lipoamide dehydrogenase.
Comparative biochemistry and physiology. B, Comparative biochemistry·1988
Affinity purification of renal dipeptidase solubilized with detergent.
Analytical biochemistry·1987
Multifunctional activities of yeast glutathione reductase.
The International journal of biochemistry·1987
Structure-activity relationship of the ring portion in backbone-cyclic C-terminal hexapeptide analogs of substance P. NMR and molecular dynamics.
International journal of peptide and protein research·1996
Conformation of a water-soluble beta-sheet model peptide. A circular dichroism and Fourier-transform infrared spectroscopic study of double D-amino acid replacements.
International journal of peptide and protein research·1996
Application of the allyloxycarbonyl protecting group for the indole of Trp in solid-phase peptide synthesis.
International journal of peptide and protein research·1996
NMR solution structure of the receptor binding domain of Pseudomonas aeruginosa pilin strain P1. Identification of a beta-turn.
International journal of peptide and protein research·1996
Kinetics of inhibition of aminoacylase activity by dithiothreitol or 2-mercaptoethanol.
International journal of peptide and protein research·1996
Alanine scan and N-methyl amide derivatives of Ac-bombesin[7-14]. Development of a proposed binding conformation at the neuromedin B (NMB) and gastrin releasing peptide (GRP) receptors.
International journal of peptide and protein research·1996
Next-generation nanocrystals of phytochemicals: overcoming bioavailability challenges and enabling targeted therapeutics.
Chemical communications (Cambridge, England)·2026